Home/Recalls/FDA-Z-2458-2026
FDA DevicesClass II

Ritmed Neurological Sponges, Description/REF: 0.5x0.5in, Non-Sterile/55992C; ...

Published: June 24, 2026Recall ID: Z-2458-2026Category: devicesCountry: US

Reason for Recall / Hazard

Neurological sponges used to moisten or absorb biological fluid during neurological surgery and may also be used to protect the brain during incision, may not consistently meet endotoxin specification for devices that contact the cerebrospinal fluid. Elevated endotoxin levels may lead to neurovascular adverse events, febrile response, and/or local transient inflammation, hypotension, or nausea.

Product Description & Identification

Ritmed Neurological Sponges, Description/REF: 0.5x0.5in, Non-Sterile/55992C; 0.5x1.0in, Non-Sterile/55993C; 0.5x3.0in, Non-Sterile/55994C; 0.75x0.75in, Non-Sterile/55995C; 1.0x1.0in, Non-Sterile/55996C; 1.0x3.0in, Non-Sterile/55997C; 0.5x1.5in, Non-Sterile/55998C

Affected Products

Ritmed Neurological Sponges, Description/REF: 0.5x0.5in, Non-Sterile/55992C; 0.5x1.0in, Non-Sterile/55993C; 0.5x3.0in, Non-Sterile/55994C; 0.75x0.75in, Non-Sterile/55995C; 1.0x1.0in, Non-Sterile/55996C; 1.0x3.0in, Non-Sterile/55997C; 0.5x1.5in, Non-Sterile/55998C

Additional Source Details

FieldValue
CityMontreal
Event id99006
Address 12555 Ch de L'Aviation
Code infoUDI-DI: 20686864043205. Distributed After May 1st, 2022, including the following lots: 19316, 16409, 15463-7, 15463-6, 15463-5, 15463-4, 15463-3, 15463-2, 15463-1, 15463, 15192-1, 15192, 14813, 14039, 13673, 13289, 12641, 12206, 11851, 11020-1, 11020, 10586, 10392, 9243, 8160, 7784, 7748, 7044
Postal codeN/A
Report date20260624
Product typeDevices
Product quantity7,838,200
Reason for recallNeurological sponges used to moisten or absorb biological fluid during neurological surgery and may also be used to protect the brain during incision, may not consistently meet endotoxin specification for devices that contact the cerebrospinal fluid. Elevated endotoxin levels may lead to neurovascular adverse events, febrile response, and/or local transient inflammation, hypotension, or nausea.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260508
Initial firm notificationLetter
Center classification date20260616

Overview

  • Recalling FirmAMD Medicom Inc.
  • StatusOngoing
  • Risk LevelClass II
  • DistributionUS: MT, NC, VA, CA, TX, OH, TN, IL, RI
Official Agency Alert